Atlas Trials

A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19

Clinical trial NCT04460183 · COMPLETED

Trial details

NCT number
NCT04460183
Sponsor
Thirty Respiratory Limited
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-07-29
Primary completion
2021-04-24
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.